Hyperparathyroidism secondary to chronic renal failure with dialysis

Hyperparathyroidism secondary to chronic renal failure with dialysis is an endocrine and metabolic complication occurring in patients with end-stage kidney disease who require renal replacement therapy The condition is driven by profound renal impairment that leads to phosphate retention, impaired activation of vitamin D (calcitriol deficiency), and systemic hypocalcemia

Hyperparathyroidism secondary to chronic renal failure with dialysis is an endocrine and metabolic complication occurring in patients with end-stage kidney disease who require renal replacement therapy

The condition is driven by profound renal impairment that leads to phosphate retention, impaired activation of vitamin D (calcitriol deficiency), and systemic hypocalcemia

These mineral imbalances trigger persistent, compensatory oversecretion of parathyroid hormone (PTH) alongside parathyroid gland hyperplasia

These mineral imbalances trigger persistent, compensatory oversecretion of parathyroid hormone (PTH) alongside parathyroid gland hyperplasia Clinically, it manifests as chronic kidney disease–mineral and bone disorder (CKD-MBD), placing dialysis patients at high risk for accelerated bone turnover, renal osteodystrophy, vascular and soft-tissue calcification, and increased cardiovascular morbidity

Clinically, it manifests as chronic kidney disease–mineral and bone disorder (CKD-MBD), placing dialysis patients at high risk for accelerated bone turnover, renal osteodystrophy, vascular and soft-tissue calcification, and increased cardiovascular morbidity